JBM (Healthcare) Limited (HKG:2161)
Hong Kong
· Delayed Price · Currency is HKD 2.460
-0.020 (-0.81%)
Apr 29, 2026, 4:08 PM HKT
JBM (Healthcare) Market Cap
JBM (Healthcare) has a market cap or net worth of 2.03 billion as of April 29, 2026. Its market cap has increased by 43.11% in one year.
Market Cap
2.03B
Enterprise Value
2.22B
Revenue
812.98M
Ranking
n/a
PE Ratio
10.07
Stock Price
2.46
Market Cap Chart
Since February 5, 2021, JBM (Healthcare)'s market cap has increased from 1.93B to 2.03B, an increase of 5.00%. That is a compound annual growth rate of 0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.01B | -7.52% |
| Dec 31, 2025 | 2.17B | 40.57% |
| Dec 31, 2024 | 1.55B | 71.27% |
| Dec 29, 2023 | 903.02M | 6.82% |
| Dec 30, 2022 | 845.38M | -8.16% |
| Dec 31, 2021 | 920.50M | -52.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chia Tai Enterprises International | 2.03B |
| Jacobson Pharma Corporation | 2.26B |
| Essex Bio-Technology | 1.80B |
| Dawnrays Pharmaceutical (Holdings) | 1.71B |
| Golden Throat Holdings Group Company | 2.61B |
| VISEN Pharmaceuticals | 2.75B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.37B |
| Hua Medicine (Shanghai) | 3.37B |